Adverse pregnancy outcomes in women with MASLD are driven by underlying metabolic comorbidities, not MASLD itself or fibrosis severity. Maternal and fetal outcomes are not affected by metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results